SUB1 and malaria: On the basis of the rational approach described here, we have predicted and experimentally demonstrated that inhibitors 1 and 2 are able to potently inhibit SUB1 enzymes of the most important human malaria pathogens, confirming that the development of pan-SUB1 inhibitors is a feasible task [11].